scientific program - World Allergy Organization

More documents

Recommendations

Info

WEDNESDAY, 10 SEPTEMBER 52 WAO Congress–XVIII ICACI Final Program WEDNESDAY, 10 SEPTEMBER - continued Free Communication Session 15:45 - 17:15 FC15 -Rhinitis Therapy Room 11, Vancouver Convention & Exhibition Centre CME Credit: 1.5 Chair: Susan Waserman, Canada Abstract #O-15-1 Additional benefit of montelukast for asthma in patients with both asthma and allergic rhinitis: analysis from the COMPACT trial Price DB 1 , Swern AS 2 , Tozzi CA 2 , Philip G 2 , Polos P 2 1 General Practice and Primary Care, University of Aberdeen, Aberdeen, UK, 2 Merck & Co., Inc., Rahway, NJ, USA Abstract #O-15-2 Effects of fexofenadine HCl on quality of life and work productivity in Japanese patients with cedar pollenosis Okubo K 1 , Okuda M 2 , Gotoh M 1 , Leahy MJ 3 , Crawford B 4 , Fujita M 5 1 Nippon Medical School, Tokyo, Japan, 2 Shimbashi Allergy Rheumatism Clinic, Tokyo, Japan, 3 Aventis Pharmaceuticals, Bridgewater, NJ, USA, 4 MAPI Value, Boston, MA, USA, 5 Waseda Clinic, Tokyo, Japan Abstract #O-15-3 The enhancement of effect by an intranasal placebo spray on the efficacy of an oral allergy tablet comparator Philpot E 1 , Toler T 1 , Rickard K 1 1 GlaxoSmithKline, Research Triangle Park, NC, USA Abstract #O-15-4 Assessment of sensory perceptions and preference to intranasal corticosteroid sprays in patients with allergic rhinitis in Delhi Khanna P 1 , Shah A 1 1 V P Chest Institute, University of Delhi, Delhi, India Abstract #O-15-5 Efficacy and safety of fexofenadine HCl 180 mg vs cetirizine 10 mg: a double-blind, randomized comparison Stewart II GE 1 , Meeves S 2 , Liao Y 2 , Georges G 2 1 Allergy and Asthma Care of Florida, Ocala, FL, USA, 2 Aventis Pharmaceuticals, Bridgewater, NJ, USA Abstract #O-15-6 Triamcinolone acetonide (Nasacort ® AQ) improves quality of life in persistent allergic rhinitis Potter PC 1 , Shoeman H 2 , Van Niekerk C 2 1 University of Cape Town, Cape Town, South Africa, 2 Aventis Pharma., Johannesburg, South Africa Presenting authors indicated in bold. SCIENTIFIC PROGRAM Congress Banquet: Northern Lights Gala Dinner and Dance 19:00 - 23:00 Location: Westin Bayshore Hotel The aurora borealis will be recreated as a magical backdrop for a Northern Lights Gala Dinner and Dance, featuring an evening of exceptional dining followed by dancing to the sounds of a 16-piece band. Dress as you would for an elegant restaurant or theatre performance. For men, a coat and tie is appropriate. For women, an evening dress or pants suit is appropriate. Attendance at the Congress Banquet is limited . Tickets for registered delegates and their guests ($75 USD each) are available on a first-come, first-served basis. Tickets are still available and may be purchased at the registration desk.
WAO Congress–XVIII ICACI Final Program THURSDAY, 11 SEPTEMBER SCIENTIFIC PROGRAM Breakfast Seminars 7:00 - 8:30 Pre-registration required. Admission by ticket only. Sessions are limited to the first 25 delegates. Breakfast Seminar tickets may be purchased, returned and exchanged at the Registration Desk located in the Lobby of the Vancouver Convention & Exhibition Centre. BR60 - Bronchitis and Asthma Room 10, Vancouver Convention & Exhibition Centre CME Credit: 1.5 Qutayba Hamid, Canada Richard Martin, United States BR61 - Asthma in Children: A Global Issue Room 13, Vancouver Convention & Exhibition Centre CME Credit: 1.5 Juan Jose Sienra Monge, Mexico Pakit Vichyanond, Thailand BR62 - Latex Allergy Room 14, Vancouver Convention & Exhibition Centre CME Credit: 1.5 Jordan Fink, United States Susan Tarlo, Canada BR63 - The Role of Allergy in Otitis Media Room 16, Vancouver Convention & Exhibition Centre CME Credit: 1.5 David Skoner, United States Paul Van Cauwenberge, Belgium BR64 - Co-Existence of Th1 and Th2 Diseases: How Frequently Does It Occur? Room 19, Vancouver Convention & Exhibition Centre CME Credit: 1.5 Sergio Romagnani, Italy BR65 - Atopic Dermatitis Room 18, Vancouver Convention & Exhibition Centre CME Credit: 1.5 Thomas Werfel, Germany BR66 - H 1 -Antihistamines: Anti-Inflammatory Effects Room 17, Vancouver Convention & Exhibition Centre CME Credit: 1.5 G. Walter Canonica, Italy Marek Jutel, Poland BR67 - Primary Immunodeficiency Diseases MacKenzie Room 1, Fairmont Waterfront Hotel CME Credit: 1.5 Rebecca Buckley, United States Hans Ochs, United States BR68 - Quality-of-Life in Allergic Rhinitis and Asthma Gazebo II, Pan Pacific Hotel CME Credit: 1.5 Michael Blaiss, United States Eli Meltzer, United States 53 BR69 - Antibody Deficiency Syndromes and Intravenous Gamma Globulin Therapy Gazebo I, Pan Pacific Hotel CME Credit: 1.5 Melvin Berger, United States Paula Busse, United States BR70 - Basophils MacKenzie Room 2, Fairmont Waterfront Hotel CME Credit: 1.5 A. Dean Befus, Canada John Schroeder, United States BR71 - Asthma and Pregnancy Cheakamus Room, Fairmont Waterfront Hotel CME Credit: 1.5 Connie Katelaris, Australia Michael Schatz, United States Plenary Session 8:45 - 10:15 PL4 - New Concepts, Part 2: Allergic Skin Disease Exhibit Hall A, Vancouver Convention & Exhibition Centre CME Credit: 1.5 Co-Chair: Michael Kaliner, United States Co-Chair: Connie Katelaris, Australia Pathogenesis of Chronic Urticaria: Idiopathic No Longer? Allen Kaplan, United States New Concepts of Inflammation in Atopic Dermatitis Thomas Bieber, Germany Eczema and Dermatitis Johannes Ring, Germany Exhibit Hall & Poster Hall Open 9:00 - 17:00 Exhibit Halls B & C, Vancouver Convention & Exhibition Centre Coffee Break 10:15 - 10:45 Exhibit Hall B, Vancouver Convention & Exhibition Centre Parallel Symposia 10:30 - 12:00 PR16 - Prevention of Asthma and Allergy (PAA) Parkview Terrace, Vancouver Convention & Exhibition Centre A program of the World Allergy Organization—IAACI (WAO) and the World Health Organization (WHO) CME Credit: 1.5 Co-Chair: Allen Kaplan, United States Co-Chair: Nikolai Khaltaev, Switzerland Environmental Influences Innes Asher, New Zealand Early Immunological Influences Patrick Holt, Australia Preventive Measures Arne Host, Denmark Recommendations Tari Haahtela, Finland THURSDAY, 11 SEPTEMBER
Page 1:
FINAL PROGRAM World Allergy Organiz
Page 4 and 5: 2 WAO Congress-XVIII ICACI Final Pr
Page 6 and 7: 4 World Allergy Organization (WAO)-
Page 8 and 9: 6 WAO Congress-XVIII ICACI Final Pr
Page 10 and 11: 8 sneezing runny nose itchy nose it
Page 12 and 13: 10 PRECAUTIONS (continued) ADVERSE
Page 14 and 15: 12 WAO Congress-XVIII ICACI Final P
Page 23 and 24: WAO Congress-XVIII ICACI Final Prog
Page 25 and 26: Whistler alpine resort WAO Congress
Page 29 and 30: XXIII EAACI Congress 12-16 June 200
Page 31 and 32: 7:00 8:00 9:00 10:00 11:00 12:00 13
Page 49 and 50: WEDNESDAY WEDNESDAY SEPTEMBER SEPTE
Page 51 and 52: www.annualmeeting.aaaai.org Visit w
Page 53: WAO Congress-XVIII ICACI Final Prog
Page 59 and 60: Presenting authors indicated in bol
Page 61 and 62: FRIDAY, 12 SEPTEMBER WAO Congress-X
Page 63 and 64: Imagine research targeting IgE, a k
Page 98 and 99: 96 PLAN TO ATTEND! SOYEZ DES NÔTRE
Page 100 and 101: 98 Dolovich, Myrna Canada BR86 Dubo
Page 102 and 103: 100 Schnuch, Axel Germany BR88 Scho
Page 104 and 105:
102 201 ACII - Journal of the World
Page 106 and 107:
104 WAO Congress-XVIII ICACI Final
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
114 Crowne Plaza Hotel Georgia 801
Page 118 and 119:
Page 120 and 121:
118 (salmeterol xinafoate/fluticaso
Page 122 and 123:
COPD, the most commonly reported dr
Page 124 and 125:
Page 126 and 127:
124 Seaplane landing at sunset Gran
Page 128:
DS2 - Dinner Symposium Monday, 8 Se
show all

scientific program - World Allergy Organization

Create successful ePaper yourself

Delete template?

Save as template?